Showing results (1481-1490 of 2,084) with videos related to

Sort By:
Pageof 209
Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic and antiarrhythmic effects of the new class III antiarrhythmic drug KCB-328 in experimental canine atrial flutterM M Rahme, G A Ungab, M Wadhwa, et al.
Indian Journal of Psychiatry|September 20, 2011
Drug abuse among non-student youth labourR Gupta, R L Narang, S Verma, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1996
Thrombin receptor-related hemostatic defect after cardiopulmonary bypassV A Ferraris, S P Ferraris, H Reich, et al.
Indian Journal of Cancer|September 15, 2009
Lipid peroxidation and antioxidants in different stages of cervical cancer: Prognostic significanceS Srivastava, S M Natu, A Gupta, et al.
Physical Review Letters|October 21, 2022
Even-Denominator Fractional Quantum Hall State at Filling Factor ν=3/4Chengyu Wang, A Gupta, S K Singh, et al.
Cancer Medicine|July 14, 2019
Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRIKatrina M Ingley, Sally M Burtenshaw, Nicole C Theobalds, et al.
Bioorganic & Medicinal Chemistry|March 7, 2007
Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidinesRajesh H Bahekar, Mukul R Jain, Ashish Goel, et al.
The Journal of Biological Chemistry|April 17, 2002
15-Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonistKevin R Kozak, Rajnish A Gupta, John S Moody, et al.
Cancer|January 22, 2026
Outcomes following definitive treatment of malignant peripheral nerve sheath tumor are significantly worse for patients with neurofibromatosis type 1: A Canadian Sarcoma Research and Clinical Collaboration studyRachel E Aubrey, Pamela Psarianos, Anna T Santiago, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2026
The Evolution of Chimeric Antigen Receptor T-Cell, Bispecific Antibodies and Antibody-Drug Conjugates for the Treatment of Multiple MyelomaLorenzo Cani, Richa Parikh, Nisha S Joseph, et al.
Pageof 209